These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 12529161)
1. Therapy for acute rejection in pediatric organ transplant recipients. Debray D; Furlan V; Baudouin V; Houyel L; Lacaille F; Chardot C Paediatr Drugs; 2003; 5(2):81-93. PubMed ID: 12529161 [TBL] [Abstract][Full Text] [Related]
2. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient. Kutzler HL; Ye X; Rochon C; Martin ST Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
5. Tacrolimus: a further update of its use in the management of organ transplantation. Scott LJ; McKeage K; Keam SJ; Plosker GL Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696 [TBL] [Abstract][Full Text] [Related]
6. Basiliximab: a review of its use as induction therapy in renal transplantation. Chapman TM; Keating GM Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658 [TBL] [Abstract][Full Text] [Related]
7. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status. Swiatecka-Urban A Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627 [TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients. Costello JM; Pahl E Paediatr Drugs; 2002; 4(11):705-15. PubMed ID: 12390042 [TBL] [Abstract][Full Text] [Related]
10. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278 [TBL] [Abstract][Full Text] [Related]
11. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Boratyńska M; Banasik M; Patrzałek D; Klinger M Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus for steroid-resistant liver rejection in children. Jara P; Robledo MJ; Frauca E; Gonzalez-Filgueira MD; Hierro L; de la Vega A; Camarena C; Martín-Ibáñez M; Murcia J; López-Santamaría M; Larrauri J; Díaz MC; Gámez M Transpl Int; 1998; 11 Suppl 1():S275-7. PubMed ID: 9664996 [TBL] [Abstract][Full Text] [Related]
13. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience. Aw MM; Taylor RM; Verma A; Parke A; Baker AJ; Hadzic D; Muiesan P; Rela M; Heaton ND; Mieli-Vergani G; Dhawan A Transplantation; 2003 Mar; 75(6):796-9. PubMed ID: 12660504 [TBL] [Abstract][Full Text] [Related]